Related references
Note: Only part of the references are listed.The single-cell pathology landscape of breast cancer
Hartland W. Jackson et al.
NATURE (2020)
Cell-type-specific signaling networks in heterocellular organoids
Xiao Qin et al.
NATURE METHODS (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
H. Raza Ali et al.
NATURE CANCER (2020)
Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models
Pramudita R. Prasetyanti et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M. Rueda et al.
NATURE (2019)
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Johanna Wagner et al.
CELL (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
The UCSC Genome Browser database: 2018 update
Jonathan Casper et al.
NUCLEIC ACIDS RESEARCH (2018)
Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts
Maurizio Callari et al.
BMC GENOMICS (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
David van Dijk et al.
CELL (2018)
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
Michael L. Beshiri et al.
CLINICAL CANCER RESEARCH (2018)
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer
Chrysiis Michaloglou et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
Darren K. Patten et al.
NATURE MEDICINE (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis
Felix J. Hartmann et al.
SCIENTIFIC REPORTS (2018)
Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer
Marie-Laure Tanguy et al.
NPJ BREAST CANCER (2018)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
Yaohua Xue et al.
NATURE MEDICINE (2017)
Mass Cytometric Analysis Reveals Viable Activated Caspase-3+ Luminal Progenitors in the Normal Adult Human Mammary Gland
David J. H. F. Knapp et al.
CELL REPORTS (2017)
The recurrent architecture of tumour initiation, progression and drug sensitivity
Andrea Califano et al.
NATURE REVIEWS CANCER (2017)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma
Jia-Jie Hao et al.
NATURE GENETICS (2016)
Earth Mover's Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations
Darya Y. Orlova et al.
PLOS ONE (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Jacob H. Levine et al.
CELL (2015)
Single-Cell Mass Cytometry Reveals Intracellular Survival/Proliferative Signaling in FLT3-ITD-Mutated AML Stem/Progenitor Cells
Lina Han et al.
CYTOMETRY PART A (2015)
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
Sylvie M. Guichard et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Hyo-eun C. Bhang et al.
NATURE MEDICINE (2015)
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy R. Yates et al.
NATURE MEDICINE (2015)
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
Euphemia Y. Leung et al.
PLOS ONE (2015)
RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
Paola Indovina et al.
ONCOTARGET (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations
Evita M. Lindholm et al.
CLINICAL CANCER RESEARCH (2014)
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Yuan Yuan et al.
NATURE BIOTECHNOLOGY (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin et al.
SCIENCE (2014)
Conditional density-based analysis of T cell signaling in single-cell data
Smita Krishnaswamy et al.
SCIENCE (2014)
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
H. Raza Ali et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Single-cell mass cytometry for analysis of immune system functional states
Zach B. Bjornson et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
A new genome-driven integrated classification of breast cancer and its implications
Sarah-Jane Dawson et al.
EMBO JOURNAL (2013)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Proteomic Portrait of Human Breast Cancer Progression Identifies Novel Prognostic Markers
Tamar Geiger et al.
CANCER RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators
Bernd Bodenmiller et al.
NATURE BIOTECHNOLOGY (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Inferring tumor progression from genomic heterogeneity
Nicholas Navin et al.
GENOME RESEARCH (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines
Patricia J. Keller et al.
BREAST CANCER RESEARCH (2010)
Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry
Dmitry R. Bandura et al.
ANALYTICAL CHEMISTRY (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Steffen Durinck et al.
NATURE PROTOCOLS (2009)
Transcriptome analysis of the normal human mammary cell commitment and differentiation process
Afshin Raouf et al.
CELL STEM CELL (2008)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue
J Stingl et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
